BEMPEDOIC ACID AND EZETIMIBE (Nexlizet) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

BEMPEDOIC ACID AND EZETIMIBE

What is the Trade Name for BEMPEDOIC ACID AND EZETIMIBE

Nexlizet

What is the Indication for BEMPEDOIC ACID AND EZETIMIBE

  • 1 INDICATIONS AND USAGE NEXLIZET is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C. NEXLIZET, which contains an adenosine triphosphate-citrate lyase (ACL) inhibitor and a cholesterol absorption inhibitor, is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C. ( 1 ) Limitations of Use : The effect of NEXLIZET on cardiovascular morbidity and mortality has not been determined. ( 1 ) Limitations of Use The effect of NEXLIZET on cardiovascular morbidity and mortality has not been determined.

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]